Yuji Kumakura 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（10 件）

• [2026] Real-world survival benefit of chemotherapy in elderly patients with advanced gastric cancer: a population-based SEER analysis
  DOI: https://doi.org/10.1038/s41598-026-50084-2
• [2026] A low-cost triangular water-filled stand-off pad to improve needle visibility in ultrasound-guided procedures
  DOI: https://doi.org/10.1186/s42155-026-00692-w
• [2026] Multicenter Study on the Safety and Efficacy of First-Line Nivolumab-Combination Chemotherapy in Patients Aged 75 Years and Older with Unresectable Advanced or Recurrent Gastric Cancer
  DOI: https://doi.org/10.1159/000550345
• [2025] Therapy-Induced Neutropenia and Poor Prognosis in Patients with Locally Advanced Esophageal Cancer Who Underwent Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil
  DOI: https://doi.org/10.3390/cancers18010112
• [2024] Prognostic Nutrition Index as a Biomarker for Treatment Sensitivity to Chemotherapy and Nivolumab as the First-Line Treatment in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study
  DOI: https://doi.org/10.1159/000541544
• [2024] ASO Visual Abstract: Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score—A Multicenter Study
  DOI: https://doi.org/10.1245/s10434-024-16313-6
• [2024] Identification of Biomarkers for Assessing Treatment Efficacy of Chemotherapy plus Nivolumab as the First Line in Patients with Unresectable Advanced or Recurrent Gastric Cancer: A Multicenter Study
  DOI: https://doi.org/10.1159/000540841
• [2024] Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Unresectable Advanced or Recurrent Gastric Cancer and a Biomarker Study Using the Gustave Roussy Immune Score: A Multicenter Study
  DOI: https://doi.org/10.1245/s10434-024-16161-4
• [2022] Case of pneumatosis cystoides intestinalis with intra‐abdominal free air developed during treatment with voglibose
  DOI: https://doi.org/10.1002/jgh3.12802
• [2022] Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer
  DOI: https://doi.org/10.1007/s10388-022-00921-w

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。